Condition: Lung Adenocarcinoma · Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
This study aims to evaluate the superiority in recurrence-free survival of lobectomy compared with segmentectomy in patients with lung adenocarcinoma ≤ 2 cm with micropapillary and solid subtype positive by intraoperative frozen sections.
This description comes directly from the study's public registry record.
Long Xu, MD · 15801783037 · xulong1228@163.com
Always discuss trial participation with your own doctor first.
| Shanghai Pulmonary Hospital | Yangpu, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05838053